Edonerpic maleate is primarily investigated for its potential cognitive-enhancing properties, particularly in the context of neurodegenerative disorders such as Alzheimer's disease. It acts as a cholinergic agent, promoting acetylcholine activity in the brain by modulating cholinergic neurotransmission, which is critical for memory and learning processes. Due to this mechanism, it has been studied as a possible treatment to improve cognitive function in patients with mild to moderate dementia. Its application focuses on restoring cholinergic deficits associated with cognitive decline, offering potential benefits in attention, memory retention, and overall mental performance. Research also explores its use in other cognitive impairments related to aging or neurological injury, though clinical development remains limited and primarily experimental.